Can Health Technology Assessment Help Control Drug Costs?

How does a health technology assessment (HTA) tool help to guide the pricing of pharmaceutical products?
Frank Lichtenberg  | Spring 2016
Print this page
Unlike many other countries, the United States does not regulate drug prices—and in 2015 drug prices there typically ran 1.5 to 3 times higher than those in other developed countries. This case asks students to analyze an actual health assessment tool for Harvoni®, a drug to treat Hepatitis C, in order to determine the best recommended pricing for this new product.

Case ID: 160311

Buy select cases through Ivey Publishing and Harvard Business Publishing.

Contact us by e-mail at Columbia CaseWorks or 646-745-8495.